(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INVIVOMAB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INVIVOMAB

ST13

US500000085902767

Class

1

Filing

85902767

Registration

4405006

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

07/21/2026

Trademark type

Word

Nice classes

1

Filing date

04/12/2013

Registration date

09/17/2013

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/27/2026

Last transaction

07/21/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

Filing basis

Intent to use

First use anywhere

01/01/2013

First use in commerce

01/01/2013

Drawing code

4

Owner type

16

Owner location

Lebanon, NH, US

Examiner

TOOLEY, DAVID E

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIO X CELL, LLC
B. C. (pessoa física)
B. C. (pessoa física)

Representatives

Jonathan M. Gelchinsky Pierce Atwood LLP

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemicalsmonoclonal antibodies that are low in endotoxins and do not contain azide or carrier proteins for in-vivo scientific research

Publications

History of USPTO decisions and trademark events.

39 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/30/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/30/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/30/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/30/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/30/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

06/27/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

06/27/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

06/27/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/24/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

02/23/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/13/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/29/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/29/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/29/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/17/2022

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

09/19/2018

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

09/19/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/19/2018

ES8R

TEAS SECTION 8 RECEIVED

09/17/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/17/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/17/2018

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

09/17/2013

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/15/2013

ALIE

ASSIGNED TO LIE

08/15/2013

AAUA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

08/02/2013

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

08/01/2013

XAEC

EXAMINER'S AMENDMENT ENTERED

08/01/2013

GRML

CORRESPONDENCE E-MAILED

08/01/2013

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/01/2013

IUAA

USE AMENDMENT ACCEPTED

08/01/2013

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

08/01/2013

IUAF

USE AMENDMENT FILED

08/01/2013

EAAU

TEAS AMENDMENT OF USE RECEIVED

07/31/2013

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/29/2013

GNRT

NON-FINAL ACTION E-MAILED

07/29/2013

CNRT

NON-FINAL ACTION WRITTEN

07/29/2013

DOCK

ASSIGNED TO EXAMINER

07/29/2013

MPMK

NOTICE OF PSEUDO MARK E-MAILED

04/19/2013

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/18/2013

Continuous trademark protection

Get notified about every new filing that threatens INVIVOMAB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.